Practical application of nitric oxide technology to the treatment of vascular diseasesLumen Therapeutics is a privately held, development stage biopharmaceutical company focused on proprietary drugs based on oligo-L-arginine. The company's lead product has completed a Phase I/IIa clinical trial for the prevention of vein graft failure after bypass graft surgery. Several additional molecules are in preclinical development. read more... |
![]() |
Lumen Therapeutics, LLC 325 Sharon Park Drive, Suite 753, Menlo Park, CA 94025 Phone: (650) 450-4439 |